PLACEBO for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where PLACEBO was used for Malignant melanoma.
Most Reported Side Effects for PLACEBO
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 18 | 5.8% | 0 | 16 |
| Blood prolactin abnormal | 15 | 4.8% | 4 | 6 |
| Sexual dysfunction | 15 | 4.8% | 4 | 6 |
| Pneumonia | 14 | 4.5% | 4 | 10 |
| Sedation | 13 | 4.2% | 4 | 6 |
| Dyskinesia | 12 | 3.9% | 4 | 6 |
| Dystonia | 12 | 3.9% | 4 | 6 |
| Vomiting | 12 | 3.9% | 0 | 11 |
| Cardiac failure | 11 | 3.5% | 3 | 8 |
| Dizziness | 11 | 3.5% | 0 | 10 |
| Anaemia | 10 | 3.2% | 0 | 10 |
| Drug ineffective | 10 | 3.2% | 4 | 1 |
| Headache | 10 | 3.2% | 0 | 8 |
| Insurance issue | 10 | 3.2% | 2 | 6 |
| Akathisia | 9 | 2.9% | 0 | 6 |
Other Indications for PLACEBO
Product used for unknown indication (16)
Rheumatoid arthritis (12)
Breast cancer (11)
Ovarian cancer (11)
Type 2 diabetes mellitus (11)
Hiv infection (10)
Cardiovascular disorder (9)
Her2 positive breast cancer (9)
Non-small cell lung cancer metastatic (9)
Pulmonary tuberculosis (8)
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)